Newer therapeutic approaches: gout

Rheumatic Diseases Clinics of North America
H Ralph Schumacher, Lan X Chen

Abstract

Newer approaches to the treatment of gout have included modifications and further attention to aspects of current therapies, and development of interesting new therapies. Colchicine prophylaxis appears to be needed longer than previously recognized after introduction of a urate-lowering agent. Diet has received attention, though most dietary effects are small. New agents under investigation include pegylated formulations of uricase and a new potent xanthine oxidase inhibitor, febuxostat. Some cardiovascular drugs have been shown to be uricosuric.

References

Jun 1, 1987·Australian and New Zealand Journal of Medicine·M J AhernM Jones
May 1, 1974·Annals of the Rheumatic Diseases·B T Emmerson
Aug 1, 1972·Metabolism: Clinical and Experimental·I H Fox, W N Kelley
Sep 15, 2001·Annals of the Rheumatic Diseases·J Vázquez-MelladoR Burgos-Vargas
Jun 22, 2002·BMJ : British Medical Journal·H Ralph SchumacherJavier Molina
Jun 10, 2003·Arthritis and Rheumatism·H Ralph Schumacher
Jul 26, 2003·Clinical Chemistry·EeMun LimJohn Beilby
Sep 19, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jacques ChanardBruno Moulin
Feb 12, 2004·Kidney International·Aud HøieggenUNKNOWN LIFE Study Group
Mar 17, 2004·Arthritis and Rheumatism·Ted R MikulsKenneth G Saag
Dec 9, 2004·Pharmacotherapy·Kerry Wilbur, Mark Makowsky
Jan 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bruno Vogt
Mar 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shuen-Iu HungYuan-Tsong Chen
May 28, 2005·Current Rheumatology Reports·Hyon K Choi
Oct 1, 2000·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·J Vázquez-MelladoR Burgos-Vargas

❮ Previous
Next ❯

Citations

Jul 27, 2007·Rheumatology International·Francesco De LeonardisFrancesco Trotta
Oct 8, 2009·Rheumatology·Tom G Rider, Kelsey M Jordan
Feb 20, 2010·Journal of Biomedicine & Biotechnology·Pollyana PfrimerFernando Araripe Gonçalves Torres
Oct 4, 2007·American Family Physician·Aaron T Eggebeen
Feb 19, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Charnelda L Gray, Nafesa E Walters-Smith
Feb 4, 2012·Current Opinion in Rheumatology·Kelsey M Jordan
Oct 2, 2020·Journal of Biomolecular Structure & Dynamics·Zahra TaherimehrMasoud Torkzadeh-Mahani
Aug 8, 2014·JAAPA : Official Journal of the American Academy of Physician Assistants·Eric Rymal, Denise Rizzolo
Oct 20, 2018·Health Information Science and Systems·Panchatcharam Parthasarathy, S Vivekanandan
Mar 26, 2015·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Erica M HillJay Higgs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.